Filing Flows

Filing Flows › Arteris (AIP) › Q2 2025

Arteris (AIP) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 5, 2025

Arteris (AIP) reported revenue of $16.5M for the second quarter 2025 (Q2 2025), +13% from a year earlier and -0.2% from the quarter before. Operating margin was -50.0%, net loss $9.1M (55.3% of revenue).

Revenue$16.5M
Year over year+13%
Quarter over quarter-0.2%
Operating margin-50.0%
Net earnings−$9.1M

Arteris, Q2 2025: revenue $16.5M (+13% year over year), operating margin -50.0%, net loss $9.1M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$16.5M-0.2%+13%
Operating profit−$8.2M——
Net earnings−$9.1M——
Operating cash flow−$2.5M-187%—

What changed

Revenue was $16.5M in Q2 2025, up 13% year over year and roughly flat from the previous quarter. Licensing, support and maintenance was the largest line at 91% of revenue. Licensing, support and maintenance added $1.5M year over year (up 11%), 80% of the total change. Other declined 76%.

Gross margin was 89.4%, down 0.6 points from a year earlier. Operating costs exceeded revenue by $8.2M, an operating margin of -50.0%. Operating expenses grew 12% against revenue growth of 13%. The fastest-growing cost line was Sales & marketing (+26%). The quarter ended with a net loss of $9.1M, wider than the previous quarter's $8.1M loss.

Operating cash flow was −$2.5M. Non-cash charges added back $845K of depreciation and amortization and $4.5M of share-based compensation. Working capital and other items added $1.3M. Capital expenditures of $355K exceeded it, leaving free cash flow of −$2.8M.

Questions

What was Arteris' revenue in the second quarter 2025?

Arteris (AIP) reported revenue of $16.5M for the second quarter 2025 (Q2 2025), +13% from a year earlier and -0.2% from the quarter before.

Was Arteris profitable in the second quarter 2025?

Operating loss was $8.2M (-50.0% of revenue) and net loss $9.1M.

Open the interactive Sankey →

Source: Arteris 10-Q on SEC EDGAR.